We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Powerhouse Energy Group Plc | LSE:PHE | London | Ordinary Share | GB00B4WQVY43 | ORD 0.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -4.55% | 1.05 | 1.00 | 1.10 | 1.05 | 1.025 | 1.05 | 5,748,520 | 09:55:06 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Scrap & Waste Materials-whsl | 380k | -46.2M | -0.0111 | -0.95 | 43.65M |
Date | Subject | Author | Discuss |
---|---|---|---|
11/7/2018 18:10 | Hi Steve, Thanks for your correction. I held srt a few years back and remember watching the directors pod casts with interest. The chat on advfn was often about the lack of patents and from memory the director replied during a pod cast that patents were expensive to aply for, and as you updated the product you had to update the patent. Then if your patent was infringed the court case would be expensive and for smal companies crippling. I will have to take a second look at SRT !. Thanks. | tenapen | |
11/7/2018 15:55 | tenapen - i know i am going to regret posting this, and mean no disrespect, but SRT do own patents US 9,473,197 and EU 2951930. having worked in an IP bureau for many years, i can safely say that applying for and owning IP is not expensive, certainly not when viewed against the cost of having your invention nicked. the guys who invented the penicillin manufacturing process decided against filing a patent, on altruistic grounds, and then a US giant took out a patent, obliging the original pioneers to pay royalties on their own invention in short, no IP is a bit like owning a fireworks factory with no smoke alarm or sprinkler system. you just wouldn't do it. i am not a holder, although i would like to be. but theres just too much downside for my liking. for all holders, i wish you the good fortune to be able to mock me and gloat at some point in the future. | steverabet | |
10/7/2018 10:58 | There is almost no downside at this level. Buy more and take a chill pill for a few months. | superbarnet | |
10/7/2018 10:44 | Good luck it will jump quickly on good news | bobbyb4 | |
10/7/2018 10:43 | I jumped out just above 0.5 as I had a feeling with no news coming that it will be pushed further down.Will buy back in if and when the news comes out if it is favourable | mertymcs | |
10/7/2018 10:34 | Looks like the market makers are trying to scare out a few weak holders from recent placing and earlier placings Bet they know there are some stop losses at these levels They have 6 to 8 weeks to gather stock when the 3rd party verification and EPC are confirmed this is a different company It's a game of cat and mouse for next couple of months How many will be spooked and how many will take a punt on potential company making news !!It's time to take your stake and roll the dice or bail and take a massive loss !!No wonder the bashers have been so vociferous of late the squeeze is on !! Good luck all long term holders not long to wait now | bobbyb4 | |
09/7/2018 00:07 | I agree, jamonit. I will be interested to learn who it is, and of course interested to learn the results. | vatnabrekk | |
08/7/2018 23:26 | No, I don't think so. I have asked that question already, but no-one has come up with an answer. Dolphin on lse asked if it might be Engsolv. I don't know, but I should think not as they are too closely involved to be "independent". | vatnabrekk | |
08/7/2018 20:02 | Must lend a hammer and some cork, appears a ship has sprung a big leak. At least we know on Aim that Companies always first disclose market sensitive information by a RNS. | nelson5100 | |
08/7/2018 19:33 | Well only 6 to 8 weeks to wait for news that will transform this company EPC and 3rd party verification will see many potential deals and partnership move from interest to firm contracts imho | bobbyb4 | |
08/7/2018 15:33 | I agree rossannan. There are more important things going on, the dual director-ships are a distraction. | vatnabrekk | |
08/7/2018 13:22 | How much is KA's remuneration at W2T? Don't know as it is a private company. What confidential information are the two directors allowed to disclose to W2T about PHE which hasn't been issued on a RNS? The recent W2T mentioned a business consultant who is in discussions in Asia. What is their business experience and are they related to the director at Dystopia Media Limited. | nelson5100 | |
07/7/2018 22:57 | Regarding the question of how directors act when they are sitting on two boards, surely this is not uncommon? I am sure that there are many individuals who sit on boards as directors of several companies, and in many cases these will be "related" companies. For example, one of the directors of the top (parent) company will usually sit as representative on the board of an associate company or JV company. Where a conflict of interest exists they will normally be required to declare that interest but they will normally still be allowed to express their point of view. I really don't see the PHE / W2T situation as anything out of the ordinary, and there is no reason why it should cause a problem. Regarding KA's situation, I don't see any potential disadvantage for PHE shareholders having him as director of both PHE and W2T. Firstly, if profits were moved from PHE to W2T that would not benefit KA as he is a director of W2T but not a shareholder. Secondly KA does in fact stand to benefit from having greater profits in PHE because he has share options in PHE. And thirdly, KA is only one director in W2T, not the CEO, so his influence in W2T is somewhat less than some people make out. For these reasons I regard the concerns that KA could manipulate profits away from PHE into the private company W2T in order to benefit himself, as completely without foundation and the stuff that conspiracy theories are made of. However I do see his dual directorship as having possible benefits to PHE shareholders, as he should be in a position to protect PHE's interests, should any such situation ever arise e.g. with regard to the sharing or distribution of profits or any other similar matters. Having said all that, I would much prefer if the W2T and PHE functions were all contained within one company, then things would be much more straightforward, and we wouldn't have to consider all of this nonsense. Sadly, I understand that there is no way that that is going to happen. | vatnabrekk | |
07/7/2018 13:18 | Yes, it is fairly clear reading the info that has been published, that the royalties of 20% of net revenues (be clear that we are talking NET revenues here, not total or gross revenues) and then, after deducting the royalties, as a JV cost, the profit figure for the JV is calculated. that Net Profit figure will be split according to the percentage shareholdings in the JV. Seemples!! | vatnabrekk | |
07/7/2018 13:17 | hTtps://twitter.com/ | simoore89 | |
07/7/2018 12:59 | Do you mean royalties are paid first and then the profits are shared equally? How are the two directors who are directors of both PHE and W2T controlled concerning discussing any confidential information of PHE when they are acting as directors of. the private company W2T? Do they act in the best interests of W2T when it could be detrimental to the public company PHE? | nelson5100 | |
07/7/2018 11:30 | PHE do not give half royalties to W2T that is just a lie and a statement to mislead The royalties or licence fee are paid after calculating profit after costs Then balance will be distributed proportionally to SPV holdersIt's quite simple really In time you could even see the plants all being made abroad by third party engineers under licence again with a fee to PHE just like ARM chips made by someone else but royalties on all income from said product What's not to like about that Royalties and recurring income create great business it keeps business alive | bobbyb4 | |
07/7/2018 09:41 | My assumption is that PHE give half of their profit to private company W2T. I preseme Howard White would never merge the two companies because I assume he wants as much of the money for himself via W2T, which it looks as if he set up to service PHE and AFC (which he also set up) as a means of taking money from related party quoted companies in return for 'services' which some might argue those companies could have undertaken themselves. Logic suggests that seems to be the purpose of the arrangement, since that will be the outcome; and since KA joined the Board of W2T last year, he would presumably become a beneficiary of this arrangement. Another critique is that why allow W2T to provide a large chunk of development finance (presumably via W2T getting finance loans) and thus take another large chunk of profits, when PHE could raise development finance themselves (via similar loans or placings, or a combination) and keep those profits for itself and its shareholders? Infact, why allow W2T to be doing anything for PHE, if PHE could presumably do a lot of it themselves and were supposed to have had plenty of sales leads earlier for the defunct Pyromex system? Also PHE had a placing a few years ago specifically to fund setting up their own sales team - which suddenly did not seeem to materialise after W2T emerged from the shadows. Finally, now KA is on the Board of W2T, PHE's technical know how is in theory also within W2T (if not necessarily yet disclosed to W2T). Could W2T or KA adapt and use it themselves without PHE in future? That should be a situation completely unacceptable to PHE shareholders and needs immediate clarification. KA said in a recent Q&A the tehnology would probably be copied at some point by someone. What if PHE shareholders want to get rid of KA in future or he decides to leave. Could he then just use or adapt PHE's technology know how via W2T, perhaps with himself or W2T also taking out patents and preventing PHE from then using it? In some ways the arrangement seems weighted towards benefitting W2T, not PHE and does not appear to me to make business sense - just private sense for W2T and its founder imo. PHE just had another dilutive share issue this week. So PHE suffer more dilution but no pain to private company W2T. All imho. | ken chung | |
07/7/2018 09:13 | It is not the case that PHE are giving all of the revenues to W2T. PHE will receive royalties of 20% of the net revenue from all projects regardless of who owns the JV, and that payment comes off before any calculation of profits. Then the net profits of the JV will be shared in accordance with the shareholding, which is the case with all JVs. I believe that W2T will get 50% of the remaining profit (but not 50% of the royalties) but to be honest I'm not clear about how this 50/50 split is supposed to work. My view is that it would be much better if PHE and W2T were to be merged into one company, then the whole thing would be much more straightforward. | vatnabrekk | |
07/7/2018 08:44 | Why they using W2T instead of hiring their own staff to do that work? It stinks. It's a stinker and it stinks. | ken chung | |
07/7/2018 08:39 | PHE paying for all the development and taking all the share dilution, then giving 50% of their profit to related party private company W2T, which seems to be the game plan especially now KA joined W2T's Board. No patents so are W2T free to walk off with the know how at some point leaving PHE shareholders stiffed? Will KA be laughing all the way to the bank now he is on the board of W2T? | ken chung | |
06/7/2018 23:56 | Held down to panic week holders into selling Now we have got final required placing completed at nominal Sp of 0.5p the city will have no need to try to drive share price lower the worry to MM now will be getting Caught short when big news drops Which it will inevitably Good luck all ing term holders only 6 to 8 weeks for 3 rd party verification and EPC completed | bobbyb4 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions